期刊文献+

不同剂量阿奇霉素和左氧氟沙星治疗呼吸道肺炎支原体感染的对照研究 被引量:2

High-dose azithromycin and levofloxacin for respiratory Mycoplasma pneumoniae infection
下载PDF
导出
摘要 目的探讨阿奇霉素和左氧氟少星快速(2d)治疗呼吸道肺炎支原体(Mp)感染的效果和可行性,为治疗Mp感染提供快捷途径。方法采用随机和对照的方法前瞻性观察随机收治的141例呼吸道Mp感染患者,年龄19~70(平均41.2)岁,分三组(性别、年龄相匹配)。组1,61例,每日予阿奇霉素10mg/kg,1次/d,po,疗程7d。组2,56例,每日子阿奇霉素10mg/kg,1次/d,po;左氧氟沙星200mg,3次/d,疗程5d。组3,24例,每日予阿奇霉素30mg/kg,1次/d,po;左氧氟沙星600mg(体重〈50kg者400mg),3次/d,疗程2d。疗程结束后随访。结果三组完成观察的分别为54、48和22例。组1、2、3,疗程结束后症状消失率分别为88.9%(48/54),91.7%(44/48)和95.5%(21/22)。组3疗效显著快于组1和组2(P〈0.001),组2显著快于组1(P〈0.001)。小于30岁和治疗及时的患者症状消失快于60岁以上(P〈0.05)和未及时治疗的患者。三组均未出现严重不良反应。随访6mo~3a,未发现异常。结论大剂量阿奇霉素和左氧氟沙星联用治疗Mp感染安全方便,起效快,疗程短,清除Mp彻底。 Objective To investigate the effect and feasibility of high-dose azithromycin and levofloxacin on treating respiratory Mycolasma pneumoniae (Mp) infection. Methods 141 respiratory Mp infected patients with average aged at 41.2 years (ranged 19-70 years) were enrolled and randomized into three groups. Group 1 contained 61 patients and received azithromycin 10 mg/kg, orally, daily for 7 days; Group 2 included 56 subjects and received azithromycin 10 mg/kg, orally, daily, and levofloxacin 200 mg orally, 3 times daily for five days. Group 3 contained 24 subjects and received azithromycin 30 mg/kg, orally, daily and levofloxacin 600 mg (bw. 〈50kg, 400 rag) orally, twice/day for two days. Results 54, 48 and 22 subjects in group l, 2 and 3 completed the follow up visits, respectively. After the last dosage, the symptoms disappeared in 88.9% (48/54), 91.7% (44/48) and 95.5% (21/22) for group 1, 2 and 3, respectively. Overall, the treatment courses was significantly shorter in group 3 than that in group 1 and 2 (P〈0.001), and group 2 has shorter treatment than group 1 (P〈0.001). Subjects 〈 30 years old recovered significantly quicker than those 〉60 years old (P〈0.05). No severe side-effects were observed in all three groups during the study and subsequent 6-36 months follow-up. Conclusions High-dose azithromycin and levofloxacin for respiratory Mp infection is a safe and effective treatment regimen with a shortened treatment course.
出处 《世界感染杂志》 2010年第5期287-290,共4页 World Journal of Infection
关键词 肺炎支原体 呼吸道感染 阿奇霉素 左氧氟沙星 Mycolasma pneumoniae Respiratory infection Azithromycin Levofloxacin
  • 相关文献

参考文献3

二级参考文献15

  • 1陈琦,孙立炜.肺炎支原体感染肺外并发症21例[J].吉林医学院学报,1996,16(1):55-57. 被引量:3
  • 2Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev, 2004, 17(4) : 697- 728. 被引量:1
  • 3Ngeow YF, Suwanjutha S, Chantarojanasriri T, et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumoniae. Int J Infect Dis, 2005, 9 (3) : 144- 153. 被引量:1
  • 4Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of maerolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother, 2004, 48( 12): 4624-4630. 被引量:1
  • 5Morozumi M, Hasegawa K, Kobayashi R, et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob Agents Chemother, 2005, 49 (6): 2302- 2306. 被引量:1
  • 6Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patient with community-acquired pneumonia. Antimicrob Agents Chemother, 2008, 52(1) : 348-350. 被引量:1
  • 7Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis on macrolide- resistant strains from Shanghai China. Antimicrob Agents Chemother, 2009, 53(5) : 2160-2163. 被引量:1
  • 8Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother, 2009, 53 ( 5 ) : 2158-2159. 被引量:1
  • 9Pereyre S, Charron A, Renaudin H, et al. First report of macrolide resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol, 2007, 45 ( 11 ) : 3534-3539. 被引量:1
  • 10Waites KB, Bebear CM, Robertson JA, et al. Cumitech 34, laboratory diagnosis of Mycoplasmal infections. Nohe FS. Washington DC, 2001 : 1-30. 被引量:1

共引文献18

同被引文献14

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部